Skip to content
The Policy VaultThe Policy Vault

Aspirin/omeprazole tablet (generic for Yosprala)Point32Health

secondary prevention of cardiovascular events

Initial criteria

  • Documentation that medication is used for secondary prevention of cardiovascular or cerebrovascular events
  • Documentation that the member is at risk of developing aspirin associated gastric ulcers
  • Member has tried and failed concurrent therapy with aspirin and omeprazole, or the provider indicates clinical inappropriateness of treatment with the individual ingredients used together
  • Documentation of treatment failure or contraindication to two generic PPIs (e.g., esomeprazole, pantoprazole, lansoprazole) in combination with aspirin